HEK293T cells adapt to serum-free medium more readily than most mammalian cell lines — but the adaptation process has one critical failure point that most protocols ignore: the suspension cells that detach during the early adaptation phase. This protocol covers the complete adaptation procedure using SimplaceX and SimplaceCDX, including how to rescue and reintegrate suspension cells instead of discarding them.
Which medium to use — SimplaceX vs SimplaceCDX
Available formats — 500 mL and 2,000 mL
| Produkt | Type | When to use |
|---|---|---|
| SimplaceX | Serum-free, protein-supplemented | Standard adaptation, research-grade and pre-clinical AAV production — easier adaptation, faster recovery of growth rate |
| SimplaceCDX | Chemically defined — no animal-derived or recombinant protein components | IND-enabling and clinical-grade AAV production where fully chemically defined medium is required for GMP documentation — slightly more demanding adaptation |
For most research and pre-clinical AAV production, start with SimplaceX. Transition to SimplaceCDX once SimplaceX adaptation is complete if chemically defined medium is required for your regulatory pathway.
The suspension cell problem — and why it matters
HEK293T cells are loosely adherent under standard culture conditions. During serum-free adaptation, the loss of adhesion-promoting serum proteins (fibronectin, vitronectin, and albumin in FBS) causes an increase in spontaneous detachment — cells that would have remained adherent in FBS-containing medium now enter suspension. Most protocols advise discarding the medium (and with it, the suspended cells) at each passage during adaptation. This is a mistake.
Suspended HEK293T cells during serum-free adaptation are not dead — they are simply detached. If discarded repeatedly, you are applying negative selection pressure for adherence at the cost of overall cell number and culture recovery rate. Instead, suspended cells should be rescued at every passage and reintegrated into the adherent culture.
Step-by-step adaptation protocol
Starting conditions
Begin with low-passage HEK293T cells (<25 passages) in standard DMEM + 10% FBS. Cells should be actively proliferating with doubling time ≤20h and >95% viability. Do not start adaptation from cells that have been under stress, over-confluent, or recently thawed from a poorly characterised vial.
- Confirm doubling time and viability before starting
- Use a T75 or T175 flask for the adaptation — not a large cell stack
- Record the passage number at the start of adaptation
Passages 1–3 — Gradual FBS reduction with SimplaceX
Replace standard DMEM + 10% FBS with the following transition medium sequence:
| Passage | Medium composition |
|---|---|
| Passage 1 | DMEM + 1% FBS + 1× SimplaceX (full volume) |
| Passage 2 | DMEM + 0.5% FBS + 1× SimplaceX |
| Passage 3 | DMEM + 0.5% FBS + 1× SimplaceX |
The 0.5–1% FBS in the first 1–3 passages slows the adaptation rate deliberately — this reduces the metabolic stress of the transition and produces a more stable adapted population. Do not skip directly to 0% FBS.
Passages 4–6 — Fully serum-free SimplaceX
Switch to DMEM + 1× SimplaceX with no FBS. This is the critical phase — detachment will increase during these passages.
At every medium change and passage, follow the suspension cell rescue protocol:
- Collect the conditioned medium from the flask into a 50 mL tube
- Centrifuge at 300 × g for 5 minutes
- Discard the supernatant
- Resuspend the cell pellet in fresh DMEM + 1× SimplaceX
- Return the resuspended suspension cells to the flask together with the trypsinised adherent cells
Monitor doubling time at each passage — expect 25–40h during this phase (slower than FBS baseline of 18–20h). This is normal.
Cell detachment — serum-free trypsinisation
In serum-free conditions, standard trypsin neutralisation with FBS is not available. Use one of these approaches:
- Option A (preferred): PBS + 5 mM EDTA — pipette gently over the cell layer for 3–5 minutes at 37°C. HEK293T cells detach without trypsin in EDTA-PBS in serum-free conditions. No enzyme inactivation step needed.
- Option B: Standard 0.05% Trypsin-EDTA — but centrifuge immediately at 300 × g for 5 min to pellet cells, aspirate all trypsin-containing supernatant, and resuspend in fresh SimplaceX. Do not allow trypsin contact beyond 3 minutes.
Passages 7–10 — Growth rate recovery
After 3–5 fully serum-free passages, cells should be adapted — meaning they proliferate consistently in SimplaceX without FBS. However, growth rate at this stage will still be 20–40% slower than the FBS baseline. This is expected and does not indicate a problem.
Growth rate recovery occurs over the next 5–20 passages as the cell population selects for individuals with the highest fitness in serum-free conditions. Continue applying the suspension cell rescue protocol at every passage — the rescued cells include those most adapted to suspension conditions and should not be discarded.
| Phase | Expected doubling time | Action |
|---|---|---|
| Passages 1–3 (FBS reduction) | 20–26h | Normal — continue protocol |
| Passages 4–6 (first serum-free) | 28–42h | Normal — rescue suspension cells every passage |
| Passages 7–10 (early adapted) | 22–32h | Improving — continue rescue protocol |
| Passages 11–25 (fully adapted) | 18–24h | Equivalent to FBS baseline — adaptation complete |
Transition to SimplaceCDX (if required)
If fully chemically defined medium (SimplaceCDX) is required for your GMP or regulatory pathway, begin the SimplaceX → SimplaceCDX transition only after cells are fully adapted to SimplaceX (stable doubling time ≤22h for at least 3 consecutive passages).
Transition protocol SimplaceX → SimplaceCDX:
- Passage 1: 75% SimplaceX + 25% SimplaceCDX
- Passage 2: 50% SimplaceX + 50% SimplaceCDX
- Passage 3: 25% SimplaceX + 75% SimplaceCDX
- Passage 4+: 100% SimplaceCDX
Apply the suspension cell rescue protocol throughout this second transition phase as well.
AAV production test — confirm equivalence before scale-up
Once cells show stable doubling time in SimplaceX or SimplaceCDX for at least 3 consecutive passages, run a small-scale AAV production test (one 15 cm dish, triple transfection) to confirm titre equivalence with your FBS baseline before scaling up production.
- Use the same plasmid preparation, PEI batch, and protocol as your FBS reference run
- Measure physical titre by qPCR and compare to FBS reference
- Accept if titre is within 2× of FBS reference — most fully adapted HEK293T in SimplaceX will reach within 1.5× of FBS titre
- If titre is >2× below FBS reference, continue adaptation for 3–5 more passages and re-test
Troubleshooting
| Problem | Wahrscheinlichste Ursache | Lösung |
|---|---|---|
| Cells not re-attaching after passage | Residual trypsin, or cells too stressed | Switch to PBS + 5 mM EDTA for detachment — eliminate trypsin entirely |
| Doubling time not recovering after passage 10 | Suspension cells discarded during adaptation — population not selected for serum-free fitness | Restart adaptation from a freshly thawed low-passage vial, apply rescue protocol rigorously from passage 1 |
| Very high suspension cell fraction (>50% of cells in suspension) | Normal during passages 4–6 — do not discard | Rescue all suspension cells at every passage — this is the protocol working correctly |
| AAV titre >2× below FBS reference after full adaptation | Cells adapted but not yet optimised for production | Continue for 5–10 more passages before re-testing — full growth rate recovery takes up to 20 passages |
| Cell clumping in suspension | EDTA depletion or calcium/magnesium in PBS | Confirm PBS is calcium- and magnesium-free (PBS −/−); add 5 mM EDTA if not already present |
Key points — summary
- Start with 0.5–1% FBS in SimplaceX for passages 1–3 — slower adaptation is more stable adaptation
- Never discard suspension cells — centrifuge, resuspend in fresh medium, and return to the flask at every passage
- Use PBS + 5 mM EDTA instead of trypsin wherever possible in serum-free conditions
- If trypsin is used, centrifuge and remove completely before resuspending — no FBS to inactivate residual trypsin
- Doubling time recovers over 5–20 passages after full serum-free adaptation — slower early growth is normal and expected
- Run a small-scale AAV production test before committing to full-scale serum-free production
- Transition to SimplaceCDX only after full SimplaceX adaptation is confirmed
SimplaceX & SimplaceCDX — Serum-Free Medium for HEK293T AAV Production
Available in 500 mL and 2,000 mL. Data sheet included. Request a sample for adaptation testing before committing to large-volume purchase.
English 
Deutsch